Article
Effective Newborn Screening for Type 1 and 3 Primary Hyperoxaluria
12 Oct 2024
Abstract excerpt
Introduction Newborn Screening programs for a defined set of eligible diseases have been enormously successful, but genomic newborn screening allowing for detection of additional treatable disorders has not been broadly implemented. All three types of primary hyperoxaluria (PH1-3) are rare autosomal recessive diseases caused by distinct defects of glyoxylate metabolism that are diagnosed genetically with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
